1. Home
  2. INZY vs SOTK Comparison

INZY vs SOTK Comparison

Compare INZY & SOTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INZY
  • SOTK
  • Stock Information
  • Founded
  • INZY 2015
  • SOTK 1975
  • Country
  • INZY United States
  • SOTK United States
  • Employees
  • INZY N/A
  • SOTK N/A
  • Industry
  • INZY Biotechnology: Pharmaceutical Preparations
  • SOTK Industrial Machinery/Components
  • Sector
  • INZY Health Care
  • SOTK Technology
  • Exchange
  • INZY Nasdaq
  • SOTK Nasdaq
  • Market Cap
  • INZY 64.9M
  • SOTK 63.0M
  • IPO Year
  • INZY 2020
  • SOTK 1987
  • Fundamental
  • Price
  • INZY $3.97
  • SOTK $3.85
  • Analyst Decision
  • INZY Buy
  • SOTK Hold
  • Analyst Count
  • INZY 9
  • SOTK 1
  • Target Price
  • INZY $15.22
  • SOTK N/A
  • AVG Volume (30 Days)
  • INZY 5.3M
  • SOTK 7.1K
  • Earning Date
  • INZY 05-14-2025
  • SOTK 05-28-2025
  • Dividend Yield
  • INZY N/A
  • SOTK N/A
  • EPS Growth
  • INZY N/A
  • SOTK N/A
  • EPS
  • INZY N/A
  • SOTK 0.08
  • Revenue
  • INZY N/A
  • SOTK $20,504,381.00
  • Revenue This Year
  • INZY N/A
  • SOTK $11.40
  • Revenue Next Year
  • INZY N/A
  • SOTK $4.12
  • P/E Ratio
  • INZY N/A
  • SOTK $48.13
  • Revenue Growth
  • INZY N/A
  • SOTK 4.08
  • 52 Week Low
  • INZY $0.72
  • SOTK $3.50
  • 52 Week High
  • INZY $6.24
  • SOTK $6.05
  • Technical
  • Relative Strength Index (RSI)
  • INZY 85.93
  • SOTK 49.21
  • Support Level
  • INZY $3.94
  • SOTK $3.64
  • Resistance Level
  • INZY $3.97
  • SOTK $4.13
  • Average True Range (ATR)
  • INZY 0.08
  • SOTK 0.21
  • MACD
  • INZY 0.12
  • SOTK -0.02
  • Stochastic Oscillator
  • INZY 99.32
  • SOTK 42.86

About INZY Inozyme Pharma Inc.

Inozyme Pharma Inc is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting bone health and blood vessel function. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies. Its product candidate, INZ-701, is a soluble, recombinant, genetically engineered fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 deficiencies.

About SOTK Sono-Tek Corporation

Sono-Tek Corp designs and manufactures ultrasonic coating systems that apply precise, thin film coatings to a multitude of products for the microelectronics/electronics, alternative energy, medical, and industrial markets, including specialized glass applications in construction and automotive. It sells products to emerging research and development and other markets. Its ultrasonic nozzle systems use high-frequency, ultrasonic vibrations that atomize liquids into minute drops that can be applied to surfaces at low velocity providing thin layers of protective materials over a surface such as glass or metals.

Share on Social Networks: